Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Change in Account Payables (2016 - 2025)

Karyopharm Therapeutics' Change in Account Payables history spans 14 years, with the latest figure at -$1.4 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 105.47% year-over-year to -$1.4 million; the TTM value through Dec 2025 reached -$1.1 million, down 155.65%, while the annual FY2025 figure was -$1.1 million, 155.65% down from the prior year.
  • Change in Account Payables reached -$1.4 million in Q4 2025 per KPTI's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.3 million in Q1 2023 to a low of -$6.8 million in Q2 2023.
  • Average Change in Account Payables over 5 years is -$22350.0, with a median of -$703500.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: tumbled 480.73% in 2021, then skyrocketed 322.17% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $722000.0 in 2021, then soared by 171.47% to $2.0 million in 2022, then grew by 11.22% to $2.2 million in 2023, then tumbled by 131.01% to -$676000.0 in 2024, then tumbled by 105.47% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Change in Account Payables are -$1.4 million (Q4 2025), $2.8 million (Q3 2025), and -$3.3 million (Q2 2025).